A head‐to‐head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene–related peptide for chronic and episodic migraine

Objective To compare the effectiveness and safety of galcanezumab, fremanezumab, and erenumab for the treatment of chronic and episodic migraine, through real‐world data. Background Monoclonal antibodies (mAbs) targeting the calcitonin gene–related peptide (CGRP) pathway have been tested extensively...

Full description

Saved in:

Bibliographic Details
Published in:	Headache Vol. 63; no. 6; pp. 788 - 794
Main Authors:	Saccà, Francesco, Braca, Simone, Sansone, Mattia, Miele, Angelo, Stornaiuolo, Antonio, De Simone, Roberto, Russo, Cinzia Valeria
Format:	Journal Article
Language:	English
Published:	United States Wiley Subscription Services, Inc 01.06.2023
Subjects:	Calcitonin Calcitonin gene-related peptide Clinical trials Cohort analysis Effectiveness erenumab fremanezumab galcanezumab Headache Headaches Migraine Monoclonal antibodies Observational studies Patients Peptides Reduction Safety calcitonin gene-related peptide migraine erenumab fremanezumab galcanezumab monoclonal antibodies
ISSN:	0017-8748, 1526-4610, 1526-4610
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!